Top 25 Companies in Global Animal Blood Plasma Products Derivative Market (2024–2035): Strategic Overview and Future Trends (2024–2035)
RELEASE DATE: Mar 2026 Author: Spherical InsightsRequest Free Sample Speak to Analyst
Introduction
Animal blood plasma products derivatives are value-added components extracted from animal blood, primarily rich in proteins such as albumin, globulins, and fibrinogen, and are widely used across multiple industries. These derivatives find applications in pharmaceuticals for vaccine production and therapeutic formulations, in animal feed to enhance immunity and growth, and in pet food as a high-quality protein source. Governments across countries are promoting sustainable livestock utilization and waste reduction through regulations and support for rendering and processing industries. Recent developments include advancements in plasma fractionation technologies and increasing investments by biotech firms to improve product quality and safety standards. News trends highlight rising demand in emerging economies due to expanding livestock industries. A key driving factor is the growing need for high-protein, functional ingredients supporting health and productivity in both humans and animals.
Navigate Future Markets with Confidence: Insights from Spherical Insights LLP
The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Animal Blood Plasma Products Derivative Market.
Market Segmentation
Global Animal Blood Plasma Products Derivatives Market Size, Share, and COVID-19 Impact Analysis, By Type (Immunoglobulin, Serum Albumin, Fibrinogen, Fetal Bovine Serum, Plasma Protein Concentrates, Cryoprecipitate, Others), By Source (Bovine, Porcine, Equine, Ovine, Caprine, Others), By Form (Liquid, Freeze-Dried Powder, Others), By Application (Pharmaceuticals & Biologics, Animal Nutrition, Veterinary Medicine, Food & Feed Industry, Cosmetics, Research & Diagnostics, Others), By End-User (Livestock Farming, Aquaculture, Pet Care, Pharmaceutical Companies, Veterinary Clinics, Research Institutes, Food Processing Companies, Others), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), Analysis and Forecast 2024–2035.
Animal Blood Plasma Products Derivative Market Size & Statistics
- The Market Size for animal blood plasma products derivatives was estimated to be worth USD 6.79 Billion in 2024.
- The Market is Going to Expand at a CAGR of 6.17% between 2024 and 2035.
- The Global Animal Blood Plasma Products Derivative Market Size is anticipated to reach USD 13.12 Billion by 2035.
- North America is expected to generate the highest demand during the forecast period in the Animal Blood Plasma Products Derivative Market
- Asia Pacific is expected to grow the fastest during the forecast period in the Animal Blood Plasma Products Derivative Market.
Regional growth and demand
Asia Pacific is expected to grow the fastest during the forecast period in the animal blood plasma products derivative market. The region’s rapid growth is driven by expanding livestock production, rising demand for high-quality animal protein, and increasing use of plasma derivatives in animal nutrition and pet food industries. Countries such as China, India, and Southeast Asian nations are witnessing strong growth in aquaculture and poultry sectors, which significantly boosts demand for plasma-based feed ingredients. Government initiatives supporting livestock health, food safety regulations, and sustainable by-product utilization are further accelerating market expansion. Additionally, growing investments in biotechnology and veterinary healthcare are enhancing the adoption of plasma-derived products across the region.
North America is expected to generate the highest demand during the forecast period in the animal blood plasma products derivative market. Demand is driven by advanced meat processing infrastructure, high adoption of premium pet food, and strong presence of leading biotechnology and pharmaceutical companies. The United States and Canada are major contributors, supported by well-established rendering industries and stringent quality standards for animal-derived products. Increasing application of plasma derivatives in pharmaceuticals, vaccines, and diagnostics further strengthens market demand. Moreover, regulatory support for animal health, continuous technological advancements in plasma fractionation, and rising focus on high-performance functional proteins contribute to sustained growth in the region.
Ready to lead the Animal Blood Plasma Products Derivative Market?
Discover the regional trends and growth factors shaping the industry. We’re here to assist with expert, personalized data.
Call +1 303 800 4326 or Send us a message for a personalized consultation.
Top 10 Trends in the Animal Blood Plasma Products Derivative Market
• Increasing demand for high-protein animal nutrition ingredients
• Rising adoption in premium pet food formulations
• Expansion of livestock and aquaculture industries
• Growing use in pharmaceutical and vaccine production
• Advancements in plasma fractionation technologies
• Increasing focus on animal health and immunity enhancement
• Sustainable utilization of animal by-products
• Expansion of biotechnology applications
• Rising investments in research and development
• Strategic partnerships among processing and biotech companies
Top 5 Trends
- Increasing Demand for High-Protein Animal Nutrition Ingredients
The growing need for efficient and nutrient-rich feed solutions is driving the adoption of plasma derivatives in animal nutrition. These products enhance feed efficiency, improve gut health, and support faster growth rates in livestock and aquaculture.
- Rising Adoption in Premium Pet Food Formulations
Pet owners are increasingly opting for high-quality, protein-rich pet food, boosting demand for plasma-based ingredients. These derivatives improve palatability, digestibility, and overall nutritional value in premium pet food products.
- Expansion of Livestock and Aquaculture Industries
Rapid growth in poultry, swine, and aquaculture farming is increasing the consumption of plasma derivatives. These products help improve animal immunity and survival rates, especially in intensive farming environments.
- Growing Use in Pharmaceutical and Vaccine Production
Animal plasma derivatives are widely used in the development of vaccines, biologics, and diagnostic products. Increasing demand for animal and human healthcare solutions is significantly supporting this trend.
- Advancements in Plasma Fractionation Technologies
Continuous innovations in processing and fractionation technologies are improving product quality, safety, and functional performance. These advancements are enabling manufacturers to expand applications across multiple industries while meeting strict regulatory standards.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Animal Blood Plasma Products Derivative Market.
Empower your strategic planning:
Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the Animal Blood Plasma Products Derivative market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.
Top 25 Companies Leading the Animal Blood Plasma Products Derivative Market
- Grifols S.A.
- CSL Limited
- Takeda Pharmaceutical Company Limited
- Octapharma AG
- Kedrion S.p.A.
- Biotest AG
- LFB Group
- China Biologic Products Holdings, Inc.
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Bio-Rad Laboratories, Inc.
- Serumwerk Bernburg AG
- Rocky Mountain Biologicals
- Biowest SAS
- Gemini Bio-Products
- Proliant Biologicals
- APC, Inc.
- Sonac
- SARIA Group
- Darling Ingredients Inc.
- Ridley Corporation Limited
- FASA Group
- Lauridsen Group Inc.
- Feedworks Pty Ltd
- Lican Food
- Grifols S.A.
Headquarters: Barcelona, Spain
Grifols S.A. is a global leader in plasma-derived products and biotechnology solutions. The company specializes in plasma fractionation and develops high-value proteins used in pharmaceuticals, diagnostics, and research. Its advanced processing capabilities and strong global presence support the development of high-quality plasma derivatives. Grifols focuses on innovation, safety standards, and expanding applications in biologics and therapeutic solutions.
- CSL Limited
Headquarters: Melbourne, Australia
CSL Limited is a major biotechnology company known for plasma-derived therapies and vaccines. The company produces a wide range of plasma proteins used in immunology and critical care. With strong R&D investments and global plasma collection networks, CSL plays a vital role in advancing plasma-based healthcare solutions and expanding market reach.
- Takeda Pharmaceutical Company Limited
Headquarters: Tokyo, Japan
Takeda Pharmaceutical Company Limited is a leading global biopharmaceutical company with a strong presence in plasma-derived therapies. The company develops innovative biologics and plasma-based treatments used in rare diseases and immune disorders. Takeda emphasizes research-driven innovation and global expansion in plasma-derived product markets.
- Octapharma AG
Headquarters: Lachen, Switzerland
Octapharma AG specializes in human and animal plasma fractionation, producing high-quality protein therapies and research-grade plasma products. The company focuses on advanced purification technologies and expanding its global footprint in plasma-based healthcare and biotechnology applications.
- Proliant Biologicals
Headquarters: Iowa, United States
Proliant Biologicals is a key player in animal plasma-derived proteins used in nutrition, pharmaceuticals, and industrial applications. The company is known for producing spray-dried plasma and functional proteins that enhance animal health and performance. Its strong focus on quality, safety, and innovation supports growing demand across global markets.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Animal Blood Plasma Products Derivative Market.
Are you ready to discover more about the Animal Blood Plasma Products Derivative market?
The report provides an in-depth analysis of the leading companies operating in the global Animal Blood Plasma Products Derivative market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:
Company Profiles
- Grifols S.A.
- Business Overview
- Company Snapshot
- Products Overview
- Company Market Share Analysis
- Company Coverage Portfolio
- Financial Analysis
- Recent Developments
- Merger and Acquisitions
- SWOT Analysis
- CSL Limited
- Takeda Pharmaceutical Company Limited
- Octapharma AG
- Kedrion S.p.A.
- Biotest AG
- LFB Group
- China Biologic Products Holdings, Inc.
- Thermo Fisher Scientific Inc.
- Others.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Animal Blood Plasma Products Derivative Market.
Conclusion
The global animal blood plasma products derivatives market is experiencing steady growth, driven by increasing demand for high-quality protein ingredients across animal nutrition, pharmaceuticals, and biotechnology industries. These derivatives are widely utilized for their functional properties, including immune support, high digestibility, and nutritional efficiency, making them essential in livestock feed, pet food, vaccine production, and diagnostic applications. The market is benefiting from the expansion of livestock and aquaculture sectors, along with rising consumer preference for premium pet nutrition products. Governments and regulatory bodies are supporting sustainable utilization of animal by-products and enforcing quality standards to ensure safety and traceability. In addition, continuous advancements in plasma fractionation technologies and growing investments in research and development are enhancing product innovation and application scope. Increasing focus on animal health, productivity, and sustainable resource utilization is expected to support the long-term expansion of the Animal Blood Plasma Products Derivatives market.
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI. Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?